Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Astrocytes | 15 | 2022 | 203 | 1.690 |
Why?
|
Manganese | 11 | 2023 | 59 | 1.600 |
Why?
|
Excitatory Amino Acid Transporter 2 | 11 | 2021 | 25 | 1.560 |
Why?
|
Ovarian Neoplasms | 9 | 2016 | 303 | 1.490 |
Why?
|
Chemokines | 4 | 2013 | 89 | 1.460 |
Why?
|
NF-kappa B | 11 | 2017 | 306 | 1.430 |
Why?
|
Granulosa Cells | 5 | 2010 | 34 | 1.310 |
Why?
|
Tumor Necrosis Factor-alpha | 10 | 2023 | 325 | 1.130 |
Why?
|
YY1 Transcription Factor | 6 | 2022 | 11 | 1.100 |
Why?
|
Receptors, Interleukin-8B | 2 | 2016 | 20 | 1.060 |
Why?
|
Soil | 3 | 2022 | 129 | 1.010 |
Why?
|
Up-Regulation | 7 | 2021 | 490 | 0.990 |
Why?
|
Plants | 3 | 2022 | 94 | 0.930 |
Why?
|
Manganese Poisoning | 4 | 2023 | 11 | 0.810 |
Why?
|
Excitatory Amino Acid Transporter 1 | 6 | 2020 | 9 | 0.790 |
Why?
|
Promoter Regions, Genetic | 12 | 2021 | 484 | 0.720 |
Why?
|
Ecosystem | 1 | 2020 | 119 | 0.680 |
Why?
|
Orosomucoid | 6 | 2001 | 12 | 0.660 |
Why?
|
Chemokine CXCL1 | 4 | 2016 | 15 | 0.650 |
Why?
|
I-kappa B Kinase | 2 | 2021 | 40 | 0.640 |
Why?
|
Serum Amyloid A Protein | 2 | 2010 | 14 | 0.630 |
Why?
|
Environmental Pollutants | 5 | 2004 | 166 | 0.610 |
Why?
|
Chemokine CCL20 | 1 | 2016 | 7 | 0.600 |
Why?
|
Repressor Proteins | 4 | 2022 | 226 | 0.540 |
Why?
|
Animals | 40 | 2023 | 14307 | 0.540 |
Why?
|
Cyclooxygenase 1 | 3 | 2015 | 11 | 0.530 |
Why?
|
Mice | 21 | 2023 | 5668 | 0.530 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2012 | 109 | 0.510 |
Why?
|
Chemokines, CXC | 2 | 2022 | 35 | 0.510 |
Why?
|
Depsipeptides | 2 | 2010 | 7 | 0.460 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 245 | 0.450 |
Why?
|
Swine | 7 | 2001 | 182 | 0.450 |
Why?
|
Estradiol | 5 | 2017 | 244 | 0.450 |
Why?
|
Signal Transduction | 11 | 2017 | 1802 | 0.440 |
Why?
|
Protein Isoforms | 2 | 2010 | 121 | 0.420 |
Why?
|
Inflammation Mediators | 1 | 2012 | 120 | 0.410 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2015 | 34 | 0.400 |
Why?
|
Swine, Miniature | 3 | 2000 | 8 | 0.390 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2012 | 200 | 0.390 |
Why?
|
Chemotactic Factors | 2 | 2007 | 7 | 0.380 |
Why?
|
Ovary | 7 | 2010 | 101 | 0.380 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 5 | 0.380 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 54 | 0.380 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2010 | 605 | 0.370 |
Why?
|
Aspirin | 1 | 2010 | 45 | 0.370 |
Why?
|
Cyclic AMP | 2 | 2010 | 125 | 0.370 |
Why?
|
Blotting, Western | 8 | 2012 | 834 | 0.350 |
Why?
|
Cells, Cultured | 12 | 2021 | 1442 | 0.350 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2004 | 32 | 0.350 |
Why?
|
Anti-Infective Agents | 2 | 2000 | 62 | 0.330 |
Why?
|
Female | 23 | 2020 | 19873 | 0.320 |
Why?
|
Transforming Growth Factor alpha | 4 | 2017 | 16 | 0.320 |
Why?
|
Valproic Acid | 2 | 2018 | 14 | 0.320 |
Why?
|
Transcription, Genetic | 5 | 2021 | 550 | 0.300 |
Why?
|
Trimethoprim | 3 | 1996 | 6 | 0.300 |
Why?
|
Tamoxifen | 3 | 2017 | 61 | 0.300 |
Why?
|
Mice, Inbred C57BL | 9 | 2018 | 1530 | 0.290 |
Why?
|
Antigens, CD | 2 | 2004 | 116 | 0.290 |
Why?
|
RNA, Messenger | 8 | 2020 | 1152 | 0.290 |
Why?
|
Interleukin-1alpha | 1 | 2006 | 17 | 0.290 |
Why?
|
Carcinoma | 1 | 2007 | 94 | 0.290 |
Why?
|
Cell Line, Tumor | 5 | 2022 | 2128 | 0.280 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 968 | 0.280 |
Why?
|
Ovulation | 4 | 2002 | 20 | 0.260 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2010 | 984 | 0.250 |
Why?
|
Receptors, Aryl Hydrocarbon | 2 | 2002 | 45 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2015 | 298 | 0.240 |
Why?
|
Disease Progression | 3 | 2016 | 580 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2003 | 24 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2015 | 781 | 0.240 |
Why?
|
Tumor Cells, Cultured | 5 | 2012 | 480 | 0.230 |
Why?
|
Cytochrome P-450 CYP1A1 | 2 | 2002 | 43 | 0.230 |
Why?
|
Serum Albumin | 5 | 2001 | 49 | 0.230 |
Why?
|
Tyrosine 3-Monooxygenase | 2 | 2020 | 72 | 0.230 |
Why?
|
Yin-Yang | 1 | 2022 | 1 | 0.230 |
Why?
|
Svalbard | 1 | 2022 | 1 | 0.230 |
Why?
|
Republic of Korea | 2 | 2020 | 103 | 0.230 |
Why?
|
Coal | 1 | 2022 | 10 | 0.220 |
Why?
|
Humans | 19 | 2023 | 34853 | 0.220 |
Why?
|
Estriol | 1 | 2002 | 8 | 0.220 |
Why?
|
Brain | 3 | 2022 | 1268 | 0.220 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 3 | 2010 | 21 | 0.220 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2002 | 22 | 0.220 |
Why?
|
Soil Microbiology | 1 | 2022 | 48 | 0.220 |
Why?
|
Oxidative Stress | 4 | 2022 | 874 | 0.220 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 57 | 0.210 |
Why?
|
Lincomycin | 3 | 2001 | 3 | 0.210 |
Why?
|
Clindamycin | 3 | 2001 | 12 | 0.210 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 165 | 0.210 |
Why?
|
Reactive Oxygen Species | 2 | 2021 | 416 | 0.210 |
Why?
|
Microglia | 2 | 2023 | 152 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 150 | 0.200 |
Why?
|
Blotting, Northern | 3 | 2010 | 139 | 0.200 |
Why?
|
Ofloxacin | 1 | 2000 | 6 | 0.200 |
Why?
|
Substantia Nigra | 1 | 2020 | 41 | 0.190 |
Why?
|
Mice, Nude | 2 | 2022 | 323 | 0.190 |
Why?
|
Anti-Bacterial Agents | 3 | 2001 | 355 | 0.190 |
Why?
|
Theca Cells | 1 | 1999 | 3 | 0.180 |
Why?
|
Cell Proliferation | 4 | 2015 | 1149 | 0.180 |
Why?
|
Histone Deacetylases | 4 | 2020 | 52 | 0.180 |
Why?
|
Steroids | 1 | 1999 | 43 | 0.180 |
Why?
|
Bacteria | 1 | 2022 | 245 | 0.180 |
Why?
|
Biodiversity | 1 | 2020 | 81 | 0.180 |
Why?
|
Erigeron | 1 | 2018 | 1 | 0.170 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 522 | 0.170 |
Why?
|
RNA, Small Interfering | 4 | 2013 | 391 | 0.170 |
Why?
|
Inflammation | 2 | 2022 | 577 | 0.160 |
Why?
|
Conservation of Natural Resources | 1 | 2018 | 32 | 0.160 |
Why?
|
Rats, Sprague-Dawley | 8 | 2016 | 1534 | 0.160 |
Why?
|
Apoptosis | 3 | 2022 | 1317 | 0.160 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2014 | 69 | 0.160 |
Why?
|
Protein Binding | 7 | 2020 | 913 | 0.160 |
Why?
|
Transcriptional Activation | 2 | 2020 | 164 | 0.160 |
Why?
|
Caprylates | 1 | 2017 | 6 | 0.160 |
Why?
|
Butyric Acid | 1 | 2017 | 17 | 0.160 |
Why?
|
Immunohistochemistry | 5 | 2015 | 859 | 0.150 |
Why?
|
Sulfonamides | 1 | 1997 | 75 | 0.150 |
Why?
|
Rats | 9 | 2016 | 3261 | 0.150 |
Why?
|
Peritoneal Cavity | 1 | 2016 | 6 | 0.150 |
Why?
|
Selective Estrogen Receptor Modulators | 2 | 2014 | 28 | 0.150 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 87 | 0.150 |
Why?
|
Anti-Infective Agents, Urinary | 1 | 1996 | 2 | 0.150 |
Why?
|
Dopamine | 1 | 2018 | 232 | 0.150 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2015 | 160 | 0.140 |
Why?
|
Gene Knockdown Techniques | 2 | 2014 | 161 | 0.140 |
Why?
|
Actinobacillus Infections | 1 | 1996 | 3 | 0.140 |
Why?
|
N-Acetylneuraminic Acid | 1 | 1996 | 7 | 0.140 |
Why?
|
Genes, Reporter | 1 | 2016 | 132 | 0.140 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 50 | 0.140 |
Why?
|
Neoplasm Invasiveness | 2 | 2015 | 247 | 0.140 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 756 | 0.140 |
Why?
|
Swine Diseases | 1 | 1996 | 9 | 0.140 |
Why?
|
Epigenesis, Genetic | 2 | 2015 | 198 | 0.140 |
Why?
|
Pregnancy, Animal | 1 | 1996 | 16 | 0.140 |
Why?
|
Transfection | 1 | 2016 | 496 | 0.130 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 40 | 0.130 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 231 | 0.130 |
Why?
|
Motor Activity | 1 | 2017 | 393 | 0.130 |
Why?
|
Cell Movement | 2 | 2015 | 545 | 0.120 |
Why?
|
Blood Proteins | 1 | 1994 | 65 | 0.120 |
Why?
|
Ovarian Follicle | 2 | 2005 | 31 | 0.120 |
Why?
|
Time Factors | 4 | 2006 | 1681 | 0.120 |
Why?
|
Ubiquitination | 1 | 2012 | 54 | 0.110 |
Why?
|
Mice, Knockout | 4 | 2020 | 897 | 0.110 |
Why?
|
Ligands | 1 | 2013 | 317 | 0.110 |
Why?
|
Aging | 2 | 1995 | 639 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 39 | 0.110 |
Why?
|
Cell Line | 3 | 2021 | 1289 | 0.110 |
Why?
|
Gene Deletion | 2 | 2022 | 156 | 0.110 |
Why?
|
Models, Biological | 4 | 2014 | 642 | 0.110 |
Why?
|
Cell Division | 2 | 2003 | 296 | 0.110 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 600 | 0.100 |
Why?
|
Injections, Intravenous | 3 | 2001 | 58 | 0.100 |
Why?
|
Area Under Curve | 3 | 2001 | 91 | 0.100 |
Why?
|
Gene Silencing | 2 | 2012 | 143 | 0.100 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 1 | 2010 | 1 | 0.100 |
Why?
|
Aromatase | 1 | 2010 | 19 | 0.090 |
Why?
|
src-Family Kinases | 2 | 2013 | 42 | 0.090 |
Why?
|
In Situ Hybridization | 1 | 2010 | 125 | 0.090 |
Why?
|
Base Sequence | 3 | 2020 | 932 | 0.090 |
Why?
|
Drug Synergism | 1 | 2010 | 171 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2004 | 366 | 0.090 |
Why?
|
Kinetics | 2 | 2004 | 650 | 0.090 |
Why?
|
RNA Interference | 1 | 2010 | 225 | 0.090 |
Why?
|
Glutamic Acid | 2 | 2021 | 115 | 0.080 |
Why?
|
Cell Cycle | 1 | 2010 | 309 | 0.080 |
Why?
|
Locomotion | 2 | 2020 | 91 | 0.080 |
Why?
|
Erythromycin | 3 | 2001 | 14 | 0.080 |
Why?
|
Gene Expression | 2 | 2018 | 639 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 162 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 139 | 0.080 |
Why?
|
Enzyme Inhibitors | 3 | 2007 | 396 | 0.080 |
Why?
|
Binding Sites | 2 | 2013 | 597 | 0.080 |
Why?
|
Interleukin-1 | 1 | 2007 | 33 | 0.080 |
Why?
|
Ultrasonography | 1 | 2007 | 115 | 0.080 |
Why?
|
Chemokine CXCL2 | 1 | 2006 | 9 | 0.070 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2006 | 84 | 0.070 |
Why?
|
Endotoxins | 1 | 2006 | 18 | 0.070 |
Why?
|
Tissue Distribution | 1 | 2006 | 197 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 200 | 0.070 |
Why?
|
Estrogen Receptor alpha | 2 | 2017 | 105 | 0.070 |
Why?
|
Isoenzymes | 2 | 2004 | 149 | 0.070 |
Why?
|
Male | 7 | 2020 | 18870 | 0.070 |
Why?
|
Phosphorylation | 2 | 2021 | 878 | 0.070 |
Why?
|
Reproduction | 1 | 2005 | 63 | 0.060 |
Why?
|
Mutation | 2 | 2023 | 1023 | 0.060 |
Why?
|
Response Elements | 2 | 2015 | 52 | 0.060 |
Why?
|
I-kappa B Proteins | 1 | 2004 | 38 | 0.060 |
Why?
|
Mutagenesis | 1 | 2004 | 87 | 0.060 |
Why?
|
Transcription Factor AP-1 | 1 | 2003 | 33 | 0.060 |
Why?
|
Acetylation | 2 | 2007 | 94 | 0.060 |
Why?
|
Protein Kinase C | 1 | 2004 | 110 | 0.060 |
Why?
|
Cerebral Cortex | 2 | 2017 | 274 | 0.060 |
Why?
|
Dioxins | 1 | 2002 | 8 | 0.060 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2002 | 2 | 0.060 |
Why?
|
Enzyme Induction | 1 | 2002 | 48 | 0.060 |
Why?
|
Indicators and Reagents | 1 | 2002 | 57 | 0.050 |
Why?
|
Luciferases | 1 | 2002 | 62 | 0.050 |
Why?
|
Inhibins | 1 | 2002 | 4 | 0.050 |
Why?
|
Receptors, Steroid | 1 | 2002 | 33 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2004 | 485 | 0.050 |
Why?
|
Teratogens | 1 | 2002 | 12 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 33 | 0.050 |
Why?
|
Autophagy | 1 | 2023 | 111 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 1 | 2002 | 185 | 0.050 |
Why?
|
Mammals | 1 | 2022 | 96 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2002 | 154 | 0.050 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2021 | 45 | 0.050 |
Why?
|
Serine | 1 | 2021 | 72 | 0.050 |
Why?
|
Manganese Compounds | 1 | 2020 | 12 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2002 | 183 | 0.050 |
Why?
|
Chlorides | 1 | 2020 | 52 | 0.050 |
Why?
|
Age Factors | 1 | 2003 | 1007 | 0.050 |
Why?
|
Transcription Factors | 2 | 2002 | 653 | 0.050 |
Why?
|
CREB-Binding Protein | 1 | 2020 | 12 | 0.050 |
Why?
|
Heme Oxygenase-1 | 1 | 2020 | 46 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2002 | 283 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2002 | 147 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2020 | 66 | 0.040 |
Why?
|
DNA | 1 | 2002 | 549 | 0.040 |
Why?
|
Cell Survival | 2 | 2017 | 818 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 73 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 1124 | 0.040 |
Why?
|
Chorionic Gonadotropin | 3 | 2005 | 13 | 0.040 |
Why?
|
Ecology | 1 | 2018 | 22 | 0.040 |
Why?
|
Down-Regulation | 1 | 2020 | 420 | 0.040 |
Why?
|
Luteinizing Hormone | 3 | 2005 | 62 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2001 | 406 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2018 | 34 | 0.040 |
Why?
|
Sulfamethazine | 1 | 1997 | 1 | 0.040 |
Why?
|
Sulfamonomethoxine | 1 | 1997 | 1 | 0.040 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2017 | 6 | 0.040 |
Why?
|
Sulfadiazine | 1 | 1997 | 4 | 0.040 |
Why?
|
Sheep | 1 | 1998 | 70 | 0.040 |
Why?
|
Malondialdehyde | 1 | 2017 | 38 | 0.040 |
Why?
|
Ovariectomy | 1 | 2017 | 104 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2017 | 72 | 0.040 |
Why?
|
Dogs | 1 | 1998 | 138 | 0.040 |
Why?
|
Rotarod Performance Test | 1 | 2017 | 13 | 0.040 |
Why?
|
Species Specificity | 1 | 1998 | 233 | 0.040 |
Why?
|
Catalase | 1 | 2017 | 106 | 0.040 |
Why?
|
Nerve Degeneration | 1 | 2017 | 101 | 0.040 |
Why?
|
Cerebellum | 1 | 2017 | 69 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 90 | 0.040 |
Why?
|
Glutathione | 1 | 2017 | 160 | 0.040 |
Why?
|
Anilino Naphthalenesulfonates | 1 | 1996 | 1 | 0.040 |
Why?
|
Cattle | 1 | 1998 | 472 | 0.040 |
Why?
|
Neuraminic Acids | 1 | 1996 | 1 | 0.040 |
Why?
|
Actinobacillus pleuropneumoniae | 1 | 1996 | 1 | 0.040 |
Why?
|
Pregnancy | 2 | 2005 | 1503 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2018 | 608 | 0.040 |
Why?
|
Quinazolines | 1 | 2016 | 31 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 1996 | 173 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 1996 | 196 | 0.030 |
Why?
|
Cytokines | 1 | 2019 | 569 | 0.030 |
Why?
|
Genome, Human | 1 | 2015 | 112 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 122 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1994 | 22 | 0.030 |
Why?
|
Estrogen Receptor beta | 1 | 2014 | 37 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 37 | 0.030 |
Why?
|
Cell Extracts | 1 | 2013 | 16 | 0.030 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 70 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 2 | 2005 | 41 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 71 | 0.030 |
Why?
|
Japan | 1 | 1994 | 296 | 0.030 |
Why?
|
Computational Biology | 1 | 2015 | 275 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 145 | 0.030 |
Why?
|
Protein Kinases | 1 | 2012 | 91 | 0.030 |
Why?
|
DNA Primers | 1 | 2012 | 269 | 0.030 |
Why?
|
Sexual Maturation | 2 | 2002 | 19 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 430 | 0.020 |
Why?
|
Adult | 2 | 2007 | 11034 | 0.020 |
Why?
|
Observer Variation | 1 | 2007 | 57 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2007 | 21 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2007 | 11 | 0.020 |
Why?
|
Histone Deacetylase 1 | 1 | 2007 | 14 | 0.020 |
Why?
|
Butyrates | 1 | 2007 | 31 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2007 | 30 | 0.020 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2007 | 33 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2007 | 41 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 89 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 164 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2007 | 528 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 649 | 0.020 |
Why?
|
Anovulation | 1 | 2005 | 4 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2005 | 45 | 0.020 |
Why?
|
Estrous Cycle | 1 | 2005 | 34 | 0.020 |
Why?
|
Protein Kinase C-delta | 1 | 2004 | 14 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2004 | 310 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 423 | 0.010 |
Why?
|
Plasminogen Inactivators | 1 | 2002 | 3 | 0.010 |
Why?
|
Plasminogen Activators | 1 | 2002 | 5 | 0.010 |
Why?
|
Hypophysectomy | 1 | 2002 | 4 | 0.010 |
Why?
|
Ribosomal Proteins | 1 | 2002 | 19 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 2002 | 66 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 2002 | 31 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2002 | 92 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 212 | 0.010 |
Why?
|
Progesterone | 1 | 2002 | 117 | 0.010 |
Why?
|
Estrus | 1 | 1999 | 14 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2002 | 486 | 0.010 |
Why?
|
Aged | 1 | 2007 | 6448 | 0.010 |
Why?
|
Middle Aged | 1 | 2007 | 9642 | 0.010 |
Why?
|